blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3252053

EP3252053 - POLYCYCLIC-CARBAMOYLPYRIDONE COMPOUNDS AND THEIR USE FOR THE TREATMENT OF HIV INFECTIONS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  19.11.2021
Database last updated on 24.08.2024
FormerThe patent has been granted
Status updated on  11.12.2020
FormerGrant of patent is intended
Status updated on  26.07.2020
FormerRequest for examination was made
Status updated on  02.06.2020
FormerGrant of patent is intended
Status updated on  06.10.2019
FormerRequest for examination was made
Status updated on  15.06.2018
FormerThe application has been published
Status updated on  03.11.2017
Most recent event   Tooltip27.04.2024Lapse of the patent in a contracting state
New state(s): MK		published on 29.05.2024  [2024/22]
Applicant(s)For all designated states
Gilead Sciences, Inc.
333 Lakeside Drive
Foster City, CA 94404 / US
[2017/49]
Inventor(s)01 / JI, Mingzhe
c/o Gilead Sciences, Inc.
333 Lakeside Drive
Foster City, CA 94404 / US
02 / MARTIN, Teresa Alejandra Trejo
c/o Gilead Sciences, Inc.
333 Lakeside Drive
Foster City, CA 94404 / US
03 / DESAI, Manoj C.
c/o Gilead Sciences, Inc.
333 Lakeside Drive
Foster City, CA 94404 / US
04 / JIN, Haolun
c/o Gilead Sciences, Inc.
333 Lakeside Drive
Foster City, CA 94404 / US
05 / PYUN, Hyung-Jung
c/o Gilead Sciences, Inc.
333 Lakeside Drive
Foster City, CA 94404 / US
 [2017/49]
Representative(s)Carpmaels & Ransford LLP
One Southampton Row
London WC1B 5HA / GB
[2017/49]
Application number, filing date17177428.411.07.2014
[2017/49]
Priority number, dateUS201361845807P12.07.2013         Original published format: US 201361845807 P
[2017/49]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3252053
Date:06.12.2017
Language:EN
[2017/49]
Type: B1 Patent specification 
No.:EP3252053
Date:13.01.2021
Language:EN
[2021/02]
Search report(s)(Supplementary) European search report - dispatched on:EP08.11.2017
ClassificationIPC:C07D471/14, A61K31/4995, A61P31/18
[2017/49]
CPC:
A61K31/4985 (EP,US); A61P31/00 (EP); A61P31/18 (EP);
C07D471/14 (EP,US); C07D471/18 (EP,US)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2018/29]
Former [2017/49]AL,  AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  RS,  SE,  SI,  SK,  SM,  TR 
TitleGerman:POLYCYCLISCHE CARBAMOYLPYRIDONVERBINDUNGEN UND DEREN VERWENDUNG ZUR BEHANDLUNG VON HIV-INFEKTIONEN[2017/49]
English:POLYCYCLIC-CARBAMOYLPYRIDONE COMPOUNDS AND THEIR USE FOR THE TREATMENT OF HIV INFECTIONS[2017/49]
French:COMPOSÉS DE CARBAMOYLPYRIDONE POLYCYCLIQUE ET LEUR UTILISATION POUR LE TRAITEMENT DES INFECTIONS PAR VIH[2017/49]
Examination procedure22.06.2017Date on which the examining division has become responsible
06.06.2018Amendment by applicant (claims and/or description)
06.06.2018Examination requested  [2018/29]
07.10.2019Communication of intention to grant the patent
26.03.2020Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time
29.05.2020Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
27.07.2020Communication of intention to grant the patent
07.12.2020Fee for grant paid
07.12.2020Fee for publishing/printing paid
07.12.2020Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP14745053.0  / EP3019499
Opposition(s)14.10.2021No opposition filed within time limit [2021/51]
Request for further processing for:The application is deemed to be withdrawn due to failure to fulfill actions required for granting the patent
29.05.2020Request for further processing filed
29.05.2020Full payment received (date of receipt of payment)
Request granted
09.06.2020Decision despatched
Fees paidRenewal fee
22.06.2017Renewal fee patent year 03
22.06.2017Renewal fee patent year 04
27.07.2018Renewal fee patent year 05
29.07.2019Renewal fee patent year 06
14.07.2020Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU11.07.2014
AL13.01.2021
AT13.01.2021
CY13.01.2021
CZ13.01.2021
DK13.01.2021
EE13.01.2021
FI13.01.2021
HR13.01.2021
LT13.01.2021
LV13.01.2021
MC13.01.2021
MK13.01.2021
PL13.01.2021
RO13.01.2021
RS13.01.2021
SE13.01.2021
SM13.01.2021
BG13.04.2021
GR14.04.2021
IS13.05.2021
PT13.05.2021
LU11.07.2021
[2024/22]
Former [2023/30]HU11.07.2014
AL13.01.2021
AT13.01.2021
CY13.01.2021
CZ13.01.2021
DK13.01.2021
EE13.01.2021
FI13.01.2021
HR13.01.2021
LT13.01.2021
LV13.01.2021
MC13.01.2021
PL13.01.2021
RO13.01.2021
RS13.01.2021
SE13.01.2021
SM13.01.2021
BG13.04.2021
GR14.04.2021
IS13.05.2021
PT13.05.2021
LU11.07.2021
Former [2023/29]HU11.07.2014
AL13.01.2021
AT13.01.2021
CZ13.01.2021
DK13.01.2021
EE13.01.2021
FI13.01.2021
HR13.01.2021
LT13.01.2021
LV13.01.2021
MC13.01.2021
PL13.01.2021
RO13.01.2021
RS13.01.2021
SE13.01.2021
SM13.01.2021
BG13.04.2021
GR14.04.2021
IS13.05.2021
PT13.05.2021
LU11.07.2021
Former [2022/23]AL13.01.2021
AT13.01.2021
CZ13.01.2021
DK13.01.2021
EE13.01.2021
FI13.01.2021
HR13.01.2021
LT13.01.2021
LV13.01.2021
MC13.01.2021
PL13.01.2021
RO13.01.2021
RS13.01.2021
SE13.01.2021
SM13.01.2021
BG13.04.2021
GR14.04.2021
IS13.05.2021
PT13.05.2021
LU11.07.2021
Former [2022/18]AL13.01.2021
AT13.01.2021
CZ13.01.2021
DK13.01.2021
EE13.01.2021
FI13.01.2021
HR13.01.2021
LT13.01.2021
LV13.01.2021
MC13.01.2021
PL13.01.2021
RO13.01.2021
RS13.01.2021
SE13.01.2021
SM13.01.2021
BG13.04.2021
GR14.04.2021
PT13.05.2021
Former [2022/10]AL13.01.2021
AT13.01.2021
CZ13.01.2021
DK13.01.2021
EE13.01.2021
FI13.01.2021
HR13.01.2021
LT13.01.2021
LV13.01.2021
PL13.01.2021
RO13.01.2021
RS13.01.2021
SE13.01.2021
SM13.01.2021
BG13.04.2021
GR14.04.2021
PT13.05.2021
Former [2022/07]AL13.01.2021
AT13.01.2021
CZ13.01.2021
DK13.01.2021
EE13.01.2021
FI13.01.2021
HR13.01.2021
LT13.01.2021
LV13.01.2021
PL13.01.2021
RO13.01.2021
RS13.01.2021
SE13.01.2021
SM13.01.2021
BG13.04.2021
GR14.04.2021
IS13.05.2021
PT13.05.2021
Former [2021/50]AT13.01.2021
CZ13.01.2021
DK13.01.2021
EE13.01.2021
FI13.01.2021
HR13.01.2021
LT13.01.2021
LV13.01.2021
PL13.01.2021
RO13.01.2021
RS13.01.2021
SE13.01.2021
SM13.01.2021
BG13.04.2021
GR14.04.2021
IS13.05.2021
PT13.05.2021
Former [2021/49]AT13.01.2021
CZ13.01.2021
DK13.01.2021
EE13.01.2021
FI13.01.2021
HR13.01.2021
LT13.01.2021
LV13.01.2021
PL13.01.2021
RS13.01.2021
SE13.01.2021
SM13.01.2021
BG13.04.2021
GR14.04.2021
IS13.05.2021
PT13.05.2021
Former [2021/48]AT13.01.2021
CZ13.01.2021
EE13.01.2021
FI13.01.2021
HR13.01.2021
LT13.01.2021
LV13.01.2021
PL13.01.2021
RS13.01.2021
SE13.01.2021
SM13.01.2021
BG13.04.2021
GR14.04.2021
IS13.05.2021
PT13.05.2021
Former [2021/46]AT13.01.2021
FI13.01.2021
HR13.01.2021
LT13.01.2021
LV13.01.2021
PL13.01.2021
RS13.01.2021
SE13.01.2021
SM13.01.2021
BG13.04.2021
GR14.04.2021
IS13.05.2021
PT13.05.2021
Former [2021/42]AT13.01.2021
FI13.01.2021
HR13.01.2021
LT13.01.2021
LV13.01.2021
PL13.01.2021
RS13.01.2021
SE13.01.2021
BG13.04.2021
GR14.04.2021
IS13.05.2021
PT13.05.2021
Former [2021/39]AT13.01.2021
FI13.01.2021
HR13.01.2021
LT13.01.2021
LV13.01.2021
PL13.01.2021
RS13.01.2021
SE13.01.2021
BG13.04.2021
GR14.04.2021
PT13.05.2021
Former [2021/38]AT13.01.2021
FI13.01.2021
HR13.01.2021
LT13.01.2021
LV13.01.2021
RS13.01.2021
SE13.01.2021
BG13.04.2021
GR14.04.2021
PT13.05.2021
Former [2021/37]AT13.01.2021
FI13.01.2021
HR13.01.2021
LT13.01.2021
LV13.01.2021
RS13.01.2021
BG13.04.2021
GR14.04.2021
PT13.05.2021
Former [2021/36]FI13.01.2021
HR13.01.2021
LT13.01.2021
BG13.04.2021
GR14.04.2021
PT13.05.2021
Former [2021/35]FI13.01.2021
HR13.01.2021
LT13.01.2021
PT13.05.2021
Former [2021/33]FI13.01.2021
LT13.01.2021
PT13.05.2021
Documents cited:Search[A]WO2006116764  (SHIONOGI & CO [JP], et al);
 [AP]WO2014100323  (GILEAD SCIENCES INC [US]);
 [AP]WO2014099586  (MERCK SHARP & DOHME [US], et al);
by applicantWO2009062285
 WO2010130034
 WO2012003497
 WO2012003498
 WO2012145728
 WO2013006738
 WO2013006792
 US2013165489
 WO2013159064
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.